BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2005
View Archived Issues
Efficacy of ambroxol in chronic pain models: Nav1.8 Na+ channels as targets for analgesia
Read More
Preclinical and clinical evaluation of a new potent and selective PDGFR inhibitor
Read More
Celera Genomics target HDACs for cancer therapy
Read More
Clusterin-targeted AS-ODN therapy: preclinical and clinical efficacy reported
Read More
SGN-40 begins phase I/II study for CLL
Read More
Roche obtains license to BCX-4208 in transplantation and autoimmune diseases
Read More
Three phase II cancer studies begin for ZK-EPO in Europe
Read More
Therapeutic cancer vaccine programs advance at Transgene
Read More
Tibotec discontinues study of TMC-125 in protease inhibitor-naive patients
Read More
Dosing begins in phase I study of NTx-265 for stroke
Read More
Veronate makes regulatory advances
Read More
OPi launches Erwinase in U.K.
Read More
Avelox approved for complicated intraabdominal infections in adults
Read More
Oral PDE5 inhibitor SLx-2101 begins phase IIa trial for erectile dysfunction
Read More
Treatment completed in phase I study of SB-509 in diabetic neuropathy
Read More
Higher doses of phenserine may be efficacious in mild to moderate Alzheimer's disease
Read More
AzaSite is effective against bacterial conjunctivitis using reduced dosing frequency
Read More
Humax-CD20 produces encouraging response rates in relapsed NHL patients
Read More
An oral nanoparticle formulation of taurine targeted for Alzheimer's
Read More
GSK's new VEGFR TK inhibitor for cancer
Read More
Natural antidiabetic agent as a potential therapy for AD
Read More
Shire submits MAA for idursulfase for Hunter's syndrome
Read More
EVOLVE evaluates MCC-135 as adjunct to primary PCI in patients with acute myocardial infarction
Read More
Preclinical and clinical data on sorafenib expands
Read More
Studies detail activity, pharmacokinetics and pharmacodynamics of sunitinib
Read More
Recent patents disclose therapeutic agents for gastrointestinal disorders
Read More
Novel therapeutics for neurological disorders reported in recent patent literature
Read More
Recent GSK patent imparts novel agents for respiratory disorders
Read More